$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
奥希替尼再度创造纪录,延长生命
2025-10-19 11:44:20
Check Details
9291最新说明书
2025-10-19 11:44:20
Check Details
靶向药9291说明书
2025-10-19 11:44:20
Check Details
9291治疗肺癌疗效
2025-10-19 11:44:20
Check Details
9291在国内上市没?
2025-10-19 11:44:20
Check Details
奥希替尼医保后还需要多少钱?
2025-10-19 11:44:20
Check Details
9291的最新说明书
2025-10-19 11:44:20
Check Details
奥希替尼获批的适应症
2025-10-19 11:44:20
Check Details
奥希替尼安全性怎么样呢?
2025-10-19 11:44:20
Check Details
肺癌一线治疗用药-奥希替尼
2025-10-19 11:44:20
Check Details
奥希替尼漏服了该怎么办?
2025-10-19 11:44:20
Check Details
奥希替尼是治什么病的?
2025-10-19 11:44:20
Check Details
1
2
...
9222
9223
9224
9225
9226
9227
9228
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
2
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
3
Opicapone Contraindications: Essential Restrictions for At-Risk Groups
4
Finerenone: An Innovative Treatment for Diabetic Kidney Disease
5
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
6
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
7
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
8
Sirolimus (Rapamune) Comprehensive Clinical Guide
9
Lusutrombopag Efficacy, Dosage and Storage Instructions
10
Icotyde (Icotrokinra) Side Effects, Pharmacokinetics and Storage Instructions
11
Cemiplimab (Libtayo) Drug Information
12
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma